INTRODUCTION
Insulin regulates the expression of over 100 gene products in multiple cell types [1] . Defects in the regulation of gene expression may underlie or contribute to the development of insulin-resistant states, such as Type II diabetes mellitus. The identification of agents that can mimic key actions of insulin, thereby overriding insulin resistance, may aid the development of treatments for such disorders. Phosphoenolpyruvate carboxykinase (PEPCK), glucose 6-phosphatase (G6Pase) and insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) are three insulin-regulated metabolic genes expressed in the liver. PEPCK and G6Pase are rate-controlling enzymes of hepatic gluconeogenesis, whereas IGFBP-1 binds to and inhibits IGFI and IGFII with high affinity. The expression of all three genes is induced by glucocorticoids and inhibited by insulin in a dominant manner [2] . Insulin mediates its actions by the regulation of signalling pathways, including the activation of phosphoinositide 3-kinase (PI 3-kinase) activity, to generate 3-phosphoinositides that in turn stimulate the activity of protein kinases, such as 3-phosphoinositide-dependent kinase (PDK1) and protein kinase B (PKB). In addition, insulin stimulates the small G-protein Ras, leading to activation of a protein kinase cascade consisting of Raf-1, mitogen-activated protein kinase (MAPK) kinase-1, p42\p44 MAPK and p90 ribosomal S6 kinase (p90RSK). The repression of PEPCK, G6Pase and IGFBP-1 by insulin is dependent on PI 3-kinase activity, but does not require activation of the p42\p44 MAPK cascade [3] [4] [5] [6] [7] . However, the identity of Abbreviations used : 4E-BP1, eIF4E-binding protein 1 ; FKHR, forkhead in rhabdomyosarcoma ; FKHR-L1, FKHR-like 1 ; GSK3, glycogen synthase kinase-3 ; G6Pase, glucose 6-phosphatase ; IGF, insulin-like growth factor ; IGFBP-1, IGF-binding protein-1 ; MAPK, mitogen-activated protein kinase ; mTOR, mammalian target of rapamycin ; p90RSK, p90 ribosomal S6 kinase ; PDK1, 3-phosphoinositide-dependent kinase ; PEPCK, phosphoenolpyruvate carboxykinase ; PI 3-kinase, phosphoinositide 3-kinase ; PKB, protein kinase B ; PP1, protein phosphatase 1 ; PP2A, protein phosphatase 2A ; S6K, ribosomal S6 protein kinase ; tIRE, thymine-rich insulin-response element. 1 To whom correspondence should be addressed (e-mail s.patel!dundee.ac.uk). the molecules linking PI 3-kinase to these gene promoters remains unclear. We have demonstrated previously [8] that inhibitors of the protein kinase glycogen synthase kinase-3 (GSK3), whose activity is reduced by insulin in a PI 3-kinase-and PKB-dependent fashion [9] , can mimic the effect of insulin on the expression of PEPCK and G6Pase. Indeed, overexpression of PKB can regulate the thymine-rich insulin-response element (tIRE) that mediates insulin repression of the IGFBP-1 gene promoter [10] [11] [12] . Taken together, these data suggest that the effect of PKB overexpression on the tIRE may be due to inhibition of GSK3. However, PKB also phosphorylates and inhibits the transcription factor FKHR (forkhead in rhabdomyosarcoma ; for review see [12] ). This protein can bind to the tIRE in itro and induces the activity of tIRE-containing promoters. This indicates a potential role for FKHR in the insulin regulation of tIRE-containing promoters. However, insulin regulation of endogenous IGFBP-1 (but not G6Pase and PEPCK) gene expression is antagonized by rapamycin, a selective inhibitor of mTOR (mammalian target of rapamycin) [4, 13] , another protein kinase thought to lie downstream of PI 3-kinase. Rapamycin blocks insulin regulation of the IGFBP-1 tIRE, but does not antagonize insulin regulation of PKB, FKHR or GSK3 [13] . Similarly, insulin regulation of mTOR activity and IGFBP-1 expression both require the presence of amino acids [13] . Amino acids do not affect insulin regulation of PKB, FKHR or GSK3. Therefore insulin regulates the expression of IGFBP-1, at least in part, by activation of an mTOR-dependent signalling pathway. Meanwhile, agents that strongly activate the MAPK cascade (e.g. phorbol esters), reduce
Figure 1 Effects of H 2 O 2 on IGFBP-1 gene expression
H4IIE cells were serum-starved overnight prior to incubation for 3 h (A, B and C) or 6 h (C) with 500 nM dexamethasone, 10 nM insulin and various concentrations of H 2 O 2 as indicated. (A-C) Total cellular RNA was isolated and an RNase-protection assay was performed to assess IGFBP-1 gene expression, as described in the Experimental section. Representative experiments showing the levels of IGFBP-1 (BP-1) and cyclophilin mRNA (A and B, middle and bottom panels respectively) as well as quantification of two such experiments performed in duplicate are shown (A and B, upper panels). Results are the meanspS.E.M., presented either as percentage gene expression relative to control (A and C) or fold induction over control (B). *P 0.05 ; ***P 0.001 ; and NS, not significant. the sensitivity of the IGFBP-1, but not the G6Pase and PEPCK, promoters to insulin [14] . All of these data suggest that distinct mechanisms are used by insulin to regulate the expression of these three genes, despite the presence of a related tIRE in all three promoters.
There is a great deal of evidence that H # O # treatment of cells can mimic many of the cellular actions of insulin. Indeed, H # O # has been hypothesized to be a potential ' second messenger ' for insulin, since nanomolar amounts of H # O # are generated in adipocytes upon stimulation with insulin [15, 16] . These insulinlike actions include the stimulation of glucose transport [17] [18] [19] , glycogen synthesis [20] , lipogenesis [17] , and the reduction of PEPCK [21] , G6Pase (P. A. Lochhead and C. Sutherland, unpublished work), cytochrome P450 1A1 (' CYP1A1 ') and cytochrome P450 1A2 (' CYP1A2 ') [22] gene expression. These effects of H # O # are linked to the regulation of the insulin signalling pathways described above. H # O # treatment of cells leads to tyrosine phosphorylation of the insulin receptor [23, 24] , the insulin receptor substrate 1 (' IRS-1 ') [25, 26] and stimulation of PI 3-kinase [27] and PKB [28, 29] 
Cell culture
The rat hepatoma cell line H4IIE was maintained in Dulbecco's modified Eagle's medium containing 1000 mg\l glucose and 5 % (v\v) foetal calf serum, as described previously [31] . Cells were incubated with the agents at 37 mC for the times and at the concentrations indicated in the Figure legends.
RNA isolation and RNase-protection assay
H4IIE cells were serum-starved overnight and treated with agent\inhibitor for the times and at the concentrations indicated in the Figure legends. Total cellular RNA was isolated using TriReagent TM (Sigma) following the manufacturer's instructions. An RNase-protection assay was performed to determine the relative amounts of IGFBP-1 and cyclophilin mRNA in each sample [14] . Band intensity was quantified on a Phosphorimager (Fuji, Straubenhardt, Germany) and data calculated as a ratio of IGFBP-1\cyclophilin mRNA and presented as fold activation (for induced samples), where the intensity of control samples was set at 1, or as percentage gene expression (for non-induced samples), where the level of gene expression in untreated cells was set at 100 %.
Preparation of cell extract for kinase assays and Western blotting
H4IIE cells were incubated in serum-free medium with the agents and inhibitors for the times and at the concentrations indicated in the Figure legends. Cells were then scraped into ice-cold lysis buffer [25 mM Tris\HCl (pH 7.4), 50 mM NaF, 100 mM NaCl, 1 mM sodium vanadate, 5 mM EGTA, 1 mM EDTA, 1 % (v\v) Triton X-100, 10 mM sodium pyrophosphate, 1 mM benzamidine, 0.1 mM PMSF, 0.27 M sucrose, 2 µM microcystin and 0.1 % (v\v) 2-mercaptoethanol]. Cell debris was removed by centrifugation at 13 000 g for 5 min and the protein concentration determined, using BSA as an internal standard, by the method of Bradford [32] .
Immunoprecipitation and assay of protein kinases
Cell extract (0.1 mg) was incubated for 1 h on a shaking platform with Protein G-Sepharose conjugated to the appropriate antibody. The immunocomplexes were pelleted and washed twice with 1.0 ml of buffer A [50 mM Tris\HCl (pH 7.5), 50 mM NaF, 500 mM NaCl, 1 mM sodium vanadate, 1 mM EGTA, 1 mM EDTA, 1 % (v\v) Triton X-100, 5 mM sodium pyrophosphate, 0.27 M sucrose and 0.1 % (v\v) 2-mercaptoethanol], and twice with 1.0 ml of buffer B [50 mM Tris\HCl (pH 7.5), 0.1 mM EGTA and 0.1 % (v\v) 2-mercaptoethanol]. The immunoprecipitated kinase activities were assayed at 30 mC, in a total volume of 50 µl containing 50 mM Tris\HCl (pH 7.5), 0.1 mM EGTA, 2.5 µM protein kinase A-inhibitor peptide, 10 mM MgCl # , 0.1 mM [γ-$#P]ATP (2i10' c.p.m.\nmol) and 30 µM crosstide (for assay of PKB and p90RSK) [9] or 30 µM long S6 peptide [for assay of ribosomal S6 protein kinase (S6K)] [33] . One unit of kinase activity was defined as the amount which catalyses the phosphorylation of 1 nmol of substrate in 1 min.
Antibodies for immunoprecipitation and Western-blot analysis
Antibodies to p90RSK, anti-phospho ribosomal protein S6 (Ser-235), phospho-specific Thr-32 FKHR-L1 (FKHR-like 1), total S6K, PH-domain-specific PKB and GSK3β were purchased from Upstate Biotechnology, and phospho-specific Ser-9\Ser-21 GSK3, Thr-308 PKB, Ser-473 PKB, Thr-389 S6K1, Thr-183\ Tyr-185 p42\p44 MAPK antibodies were purchased from New England Biolabs (Hitchin, Herts., U.K.). The phosphospecific and control eIF4E-binding protein 1 (4E-BP1) antibodies were a gift from Professor C. G. Proud (Department of Anatomy and Physiology, University of Dundee, Dundee, U.K.). H4IIE cell lysates were prepared following incubation with the agents, as described in Figure legends , and analysed by Western-blot analysis [31] . A similar procedure was performed for 4E-BP1, except an Immobilion TM -P membrane (Millipore, Watford, Herts., U.K.) replaced nitrocellulose and proteins were fixed with glutaraldehyde prior to incubation with primary and secondary antibodies.
PI 3-kinase assay
PI 3-kinase was immunoprecipitated from H4IIE lysate using 1 µg of anti-phosphotyrosine antibody (PY20 ; Affinity Research, Mamhead, Exeter, Devon, U.K.) and assayed as described previously [30] .
Lipid extraction
H4IIE cells (60 mm dishes) were serum-starved overnight prior to incubation for 10 min at 37 mC with the agents, as indicated in the Figure legends. Lipids were harvested by addition of 1 ml of ice-cold 10 % (v\v) tricholoroacetic acid and centrifugation at 14 000 g for 5 min at 4 mC. Pellets were washed with 0.5 ml of icecold 5 % (v\v) tricholoroacetic acid \1 mM EDTA and extracted with 0.75 ml of chloroform\methanol\HCl (20 : 40 : 1, by vol.). After standing on ice for 20 min, 0.25 ml of chloroform and 0.45 ml of 0.1 M HCl were added, the samples were vortexed and centrifuged at 12 000 g for 2 min at 4 mC. The lower organic phase was transferred to a clean screw-cap Eppendorf tube, the upper aqueous phase was re-extracted with 0.5 ml of chloroform\methanol\HCl (1 : 1 : 0.9, by vol.) and the organic phases pooled. Extracted lipids were dried and alkaline hydrolysed. The concentration of the released Ins(1,3,4,5)P % [the polar headgroup of PtdIns(3,4,5)P $ ] was measured using a radioligand displacement assay as described previously [30] . Briefly, displacement of [3-$$P]Ins(1,3,4,5)P % from recombinant GAP1 IP%BP (a Ras GTPase-activating protein) by sample-derived Ins(1,3,4,5)P % [or authentic Ins(1,3,4,5)P % for calibration] was measured by scintillation counting.
RESULTS AND DISCUSSION

H 2 O 2 regulation of IGFBP-1 gene expression
Oxidative stress (e.g. H # O # ) has long been known to modulate cellular metabolism and regulate the expression of various genes (for review see [34] ). In numerous studies, H # O # has been shown to enhance and even mimic the cellular actions of insulin. The regulation of basal and glucocorticoid-induced IGFBP-1 gene expression is dominantly blocked by insulin in H4IIE cells.
Treatment of these cells with H
# O # caused a small reduction (approx. 40 %) in basal expression of IGFBP-1 ( Figure 1A) . In contrast, the glucocorticoid-induced expression of IGFBP-1 was much more markedly reduced by the presence of an equivalent concentration of H # O # ( Figure 1B ). It has been reported previously [35] that H # O # reduces glucocorticoid receptor activity, and this may underlie the reduction of glucocorticoid-induced IGFBP-1 gene expression. In this respect, this is an insulin-like effect of H # O # . However, most interestingly, insulin repression of basal (or glucocorticoid-induced) IGFBP-1 expression was actually blocked by the presence of H # O # (Figures 1A-1C ). This is in contrast with the insulin ' mimetic ' effects of H # O # on PEPCK [21] or G6Pase (P. A. Lochhead and C. Sutherland, unpublished work) gene expression in the same cell line. The antagonistic effects of H # O # on this insulin action were observed in cells incubated for up to 3 h, but were lost at longer incubation times 
H 2 O 2 regulation of PI 3-kinase and PKB
Within the liver, insulin-induced tyrosine phosphorylation of insulin receptor substrate 1 and activation of PI 3-kinase can be mimicked by the administration of H # O # [27] . In agreement with this, we observed an increase in the accumulation of the product of the PI 3-kinase reaction [PtdIns (3, 4, 5) (Table 1) , although we could not detect a significant stimulation of PI 3-kinase activity in anti-phosphotyrosine immunoprecipitates (Table 1) . This may reflect the difference in sensitivity of these two techniques. Importantly, H # O # did not inhibit insulin-induced PI 3-kinase activity (Table 1) or insulin stimulated production of PtdIns(3,4,5)P $ (Table 1) . Next, we examined the regulation of PKB and two of its substrates, GSK3 and FKHR-L1. H # O # and insulin potently activated PKB in H4IIE cells, whereas simultaneous treatment resulted in an additive induction of PKB activity (Figures 2A and 2B ). This activation was accompanied by an equivalent level of phosphorylation of PKB (Thr-308), GSK3α (Ser-21), GSK3β (Ser-9) and FKHR-L1 (Thr-32) (Figures 2C and 2D) . Similar results were obtained when H4IIE cells were treated for 30 min or 3 h (Figure 2) . Phosphorylation of Thr-308 correlates with the activation of PKB, whereas phosphorylation of GSK3β on Ser-9, GSK3α on Ser-21 and FKHR-L1 on Thr-32 is indicative of inhibition of these PKB substrates. The inhibition of GSK3 by H # O # may well account for the inhibition of PEPCK [21] and G6Pase (P. A. Lochhead and C. Sutherland, unpublished work) expression following H # O # treatment of liver cells, since selective inhibitors of GSK3 also reduce PEPCK and G6Pase gene expression [8] . However, our data suggest that the mechanism by which H # O # attenuates insulin regulation of IGFBP-1 gene expression is not due to inhibition of PI 3-kinase, the PKB\GSK3 or PKB\FKHR-L1 pathways. This is consistent with previous data [4, 13] demonstrating that insulin regulates IGFBP-1 in an mTOR-dependent fashion, as opposed to the mechanism that has been proposed for certain tIRE-containing promoters (a PI 3-kinase-and PKB-dependent inhibition of the transcription factor FKHR [36] ). 
H 2 O 2 regulation of p42/p44 MAPK
Insulin and H # O # both activate the p42\p44 MAPK pathway ; however, the activation by H # O # was much stronger than that observed with insulin, as judged by the phosphorylation of Thr-183 and Tyr-185 of p42\p44 MAPK (Figures 2C and 2D) . We have demonstrated previously [14] that phorbol ester treatment of H4IIE cells can block insulin regulation of IGFBP-1 gene expression and that part of this effect is mediated by a strong activation of the p42\p44 MAPK. Therefore we investigated whether the activation of this pathway by H # O # underlies its antagonism of insulin regulation of the IGFBP-1 gene. However, in contrast with phorbol esters, the action of H # O # on IGFBP-1 expression was not blocked by the presence of PD184352 ( Figure   3A ), at concentrations that fully inhibited insulin-or H # O # -induced activation of p42\p44 MAPK and its substrate p90RSK ( Figures 3B and 3C ). Thus we conclude that this pathway is not required for H # O # antagonism of insulin regulation of the IGFBP-1 gene.
H 2 O 2 regulation of mTOR signalling
Insulin regulates protein translation, in part, through the activation of S6K and the resultant phosphorylation of ribosomal S6 protein, but also through the phosphorylation and regulation of 4E-BP1 [37] . These processes are dependent on mTOR activity, as they are antagonized by rapamycin and require the presence of amino acids [38, 39] . We have demonstrated previously [3, 13] that rapamycin or amino acid withdrawal antagonizes insulin regulation of IGFBP-1 (but not G6Pase or PEPCK) gene expression. Therefore we examined whether H Figure 4C ), but was not affected after a 3 h incubation ( Figure 4D ). Thus H # O # transiently antagonizes the insulin regulation of S6K.
Next, we examined the hyperphosphorylation of 4E-BP1, a postulated physiological substrate for mTOR. 4E-BP1 is reported to migrate on SDS\PAGE as distinct species (α, β and γ) [40] . The α band (fastest migration) is the least phosphorylated form, whereas the γ band (slowest migration) is the most phosphorylated. Insulin induces formation of the γ species in an mTOR-and amino acid-dependent fashion (for review see [37] ). We observed at least two of these species (the β and γ species) using an antibody to the native 4E-BP1 or an antibody that recognized 4E-BP1 phosphorylated at Thr-70 ( Figures 4C and  4D) . When H4IIE cells were deprived of serum, 4E-BP1 migrated as the β and γ species, with these components being present in similar amounts (Figures 4C and 4D) . However, the presence of 10 nM insulin induced a shift towards the most highly phosphorylated γ species, whereas treatment with H # O # alone increased its mobility towards the less highly phosphorylated β form. The ability of insulin to induce the shift toward the γ species was antagonized by treatment of the cells with H # O # for 30 min (Figure 4C ), but not by treatment for 3 h ( Figure 4D ). Thus H # O # antagonizes insulin regulation of two mTORdependent signalling pathways. A reduction in 4E-BP1 phosphorylation has also been observed in H # O # -treated cardiac myocytes [41] ; however, insulin regulation of PKB was also reduced in these cells, suggesting an antagonism of more than just mTOR signalling. Similarly, insulin, but not platelet-derived growth factor (' PDGF '), activation of both S6K and PKB is reduced upon H # O # treatment of adipocytes [42] . However, our data demonstrate that H # O # does not antagonize the activation of PKB in H4IIE cells, but does impair insulin signalling through the mTOR pathway. This may be achieved by the direct inhibition of mTOR, or through the transient activation of a phosphatase that selectively targets 4E-BP1 and S6K. H # O # regulation of a protein phosphatase 1 (PP1)\protein phosphatase 2A (PP2A)-type phosphatase has been reported previously [43] . Therefore we examined whether okadaic acid blocked the action of H # O # ( Figure 5A ). The presence of okadaic acid, at concentrations known to inhibit both PP1 and PP2A, did not reduce the H # O # antagonism of insulin action. This was the case whether phosphorylation of S6 or hyperphosphorylation of 4E-BP1 was measured ( Figure 5A ). Therefore H # O # does not require activation of PP1 or PP2A to antagonize insulin regulation of mTOR signalling, at least in H4IIE cells.
S6K and PKB are both members of the protein kinases A-, Gand C-related (' AGC ') kinase family (for review see [44] ) and are regulated by insulin-induced phosphorylation of two specific residues, one within the T-loop and one within a hydrophobic motif present within each protein kinase domain [44] . Interestingly, using phospho-specific antibodies, we found that H # O # impaired insulin-induced phosphorylation of S6K at Thr-389 (the hydrophobic motif residue), but not the phosphorylation of the equivalent regulatory residue on PKB, namely Ser-473 ( Figure 5B ). This effect was observed after treatment of H4IIE cells with H # O # for 30 min, but lost after a 3 h incubation ( Figures 5B and 5C ). Since the phosphorylation of Thr-389 of S6K (but not Ser-473 of PKB) is sensitive to rapamycin, it is likely that this effect is due to a direct inhibition of mTOR by H # O # . Thus we hypothesize that H # O # antagonizes mTOR activity\signalling and that this ultimately blocks insulin regulation of IGFBP-1 gene expression.
Conclusions
Although many studies have indicated that generation of H # O # would have beneficial effects on glucose disposal and hepatic glucose production in insulin-resistant states [21] [22] [23] [24] [25] [26] [27] [28] [29] , our finding that it also antagonizes mTOR signalling has major implications for the use of H # O # -generating agents as insulin mimetics. As rapamycin is currently being used as an immunosuppressant in kidney transplantation, it will soon be possible to determine whether there are risks associated with inhibition of mTOR. Indeed, it will be interesting to determine whether these patients develop any defects in glucose homoeostasis. Conversely, oxidative stress, leading to reduced mTOR signalling, may play a role in the development of insulin resistance. Recent epidemiological evidence proposes a role for inflammation in the development of Type II diabetes [45] . In the present study, we show that H # O # antagonizes insulin regulation of IGFBP-1 gene expression in H4IIE cells, and that this is mediated through a reduction of mTOR-regulated pathways and not PI 3-kinase or PKB activity. This is not only consistent with an important role for mTOR activity in the regulation of IGFBP-1 gene transcription, but also provides another example of distinct regulation of PEPCK and IGFBP-1 gene expression. Indeed, the data suggest that oxidative stress would block mTOR signalling in the liver, while stimulating events downstream of PKB signalling. This may have beneficial effects on some aspects of insulin resistance, but would also provide a reduction in the ability of insulin to regulate protein synthesis and expression of specific genes (e.g. IGFBP-1, Na + \P i -cotransporter-1 [46] , and hexokinase-II [47] ), thereby producing a form of insulin resistance. 
